The paired availability design: A proposal for evaluating epidural analgesia during labor
- 15 November 1994
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 13 (21), 2269-2278
- https://doi.org/10.1002/sim.4780132108
Abstract
The paired availability design (PAD) can reduce selection bias when it is not possible to randomize subjects. PAD consists of independent pairs of experimental and control groups. Within each pair, the intervention is the availability of treatment not its receipt. In the experimental group, the new treatment is made available to all subjects although some may not receive it. In the control group, the experimental treatment is generally not available to subjects although some may receive it in special circumstances. We present a statistic to test a null hypothesis that the receipt of intervention will increase response by a specified non‐zero amount δ. We propose this design for use in a study of the effect of epidural analgesia on the rate of Caesarean section.Keywords
This publication has 11 references indexed in Scilit:
- Aspects of statistical design for the community intervention trial for smoking cessation (COMMIT)Controlled Clinical Trials, 1992
- Epidural analgesia and cesarean section for dystociaAmerican Journal of Obstetrics and Gynecology, 1990
- Randomized consent designs for clinical trials: An updateStatistics in Medicine, 1990
- The effect of continuous epidural analgesia on cesarean section for dystocia in nulliparous womenAmerican Journal of Obstetrics and Gynecology, 1989
- “Proving the null hypothesis” in clinical trialsControlled Clinical Trials, 1982
- The influence of lumbar epidural analgesia in labor on mode of deliveryInternational Journal of Gynecology & Obstetrics, 1982
- For debate: Do retrospective controls make clinical trials "inherently fallacious?".BMJ, 1979
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979
- Randomized Clinical TrialsNew England Journal of Medicine, 1976
- Non-Randomized Controls in Cancer Clinical TrialsNew England Journal of Medicine, 1974